NO155476C - Fremgangsmaate til fremstilling av en kapsel inneholdende acetylsalicylsyre. - Google Patents

Fremgangsmaate til fremstilling av en kapsel inneholdende acetylsalicylsyre.

Info

Publication number
NO155476C
NO155476C NO812678A NO812678A NO155476C NO 155476 C NO155476 C NO 155476C NO 812678 A NO812678 A NO 812678A NO 812678 A NO812678 A NO 812678A NO 155476 C NO155476 C NO 155476C
Authority
NO
Norway
Prior art keywords
preparing
procedure
acetylsalicylic acid
capsule containing
containing acetylsalicylic
Prior art date
Application number
NO812678A
Other languages
English (en)
Other versions
NO812678L (no
NO155476B (no
Inventor
Thomas M Tencza
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/179,191 external-priority patent/US4294819A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO812678L publication Critical patent/NO812678L/no
Publication of NO155476B publication Critical patent/NO155476B/no
Publication of NO155476C publication Critical patent/NO155476C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO812678A 1980-08-18 1981-08-07 Fremgangsmaate til fremstilling av en kapsel inneholdende acetylsalicylsyre. NO155476C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/179,191 US4294819A (en) 1980-08-18 1980-08-18 Alkaline analgesic capsule
US06/273,015 US4339428A (en) 1980-08-18 1981-06-18 Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component

Publications (3)

Publication Number Publication Date
NO812678L NO812678L (no) 1982-02-19
NO155476B NO155476B (no) 1986-12-29
NO155476C true NO155476C (no) 1987-04-08

Family

ID=26875096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812678A NO155476C (no) 1980-08-18 1981-08-07 Fremgangsmaate til fremstilling av en kapsel inneholdende acetylsalicylsyre.

Country Status (25)

Country Link
US (1) US4339428A (no)
AT (1) AT370624B (no)
AU (1) AU549488B2 (no)
CA (1) CA1156554A (no)
CH (1) CH646331A5 (no)
DD (1) DD201643A5 (no)
DE (1) DE3132518A1 (no)
DK (1) DK159374C (no)
ES (1) ES504797A0 (no)
FI (1) FI77371C (no)
FR (1) FR2488508A1 (no)
GB (1) GB2082456B (no)
GR (1) GR74618B (no)
HU (1) HU187354B (no)
IE (1) IE51501B1 (no)
IL (1) IL63577A0 (no)
IT (1) IT1143221B (no)
LU (1) LU83559A1 (no)
NL (1) NL8103804A (no)
NO (1) NO155476C (no)
NZ (1) NZ198045A (no)
OA (1) OA06883A (no)
PT (1) PT73530B (no)
SE (1) SE451667B (no)
ZW (1) ZW19781A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
EP0320550A1 (en) * 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
US5071842A (en) * 1988-10-14 1991-12-10 Bristol-Myers Squibb Company Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
JP3230814B2 (ja) * 1989-09-15 2001-11-19 シーマ・ラブス、インコーポレイション 炭酸マグネシウムおよびオイルタブレット形成助剤
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
HU9202318D0 (en) * 1991-07-22 1992-10-28 Bristol Myers Squibb Co Method for preparing medical preparatives containing didesoxi-purine nucleoside
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
US5391230A (en) * 1993-07-07 1995-02-21 Eastman Kodak Company Apparatus for holding solid compact medicaments during processing
JPH10505087A (ja) * 1994-09-02 1998-05-19 バージニア カマンウェルス ユニバーシティ 非麻薬性鎮痛剤および無痛エンハンサーを含有する疼痛緩和組成物
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US6511494B1 (en) 2000-11-17 2003-01-28 Embro Corporation Vein harvesting system and method
US6887492B2 (en) * 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
US6576665B2 (en) * 2001-04-03 2003-06-10 Braintree Laboratories, Inc. Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
EP1455763B1 (en) * 2001-12-21 2007-10-03 Supernus Pharmaceuticals, Inc. Oral capsule formulation with increased physical stability
CN1802178A (zh) * 2003-06-06 2006-07-12 武田药品工业株式会社 固体制剂
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050282756A1 (en) * 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US20060222705A1 (en) * 2005-03-31 2006-10-05 Flanner Henry H Pharmaceutical tablet and apparatus and method for making
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
DE102008025798C5 (de) 2008-05-29 2015-08-06 Guangdong Fushan Glass Machinery Co., Ltd. Verfahren zum Betreiben eines Rollenofens
US20110061345A1 (en) * 2009-06-29 2011-03-17 Cherukuri S Rao Solid and semi-solid dosage forms and systems and methods for forming and packaging thereof
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
US20130143867A1 (en) * 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses
EP3003297A4 (en) 2013-06-05 2017-04-19 Synchroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
EP3359131A4 (en) * 2015-10-09 2019-05-01 Combocap, Inc. CAPSULE WITH INTERNAL MEMBRANES FOR IMPROVED BIOVERABILITY

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA593581A (en) * 1960-03-01 W. E. Harrisson Joseph Analgesic product
FR808949A (fr) * 1936-07-31 1937-02-18 Perfectionnements à la préparation des cachets pharmaceutiques
US2224256A (en) * 1938-08-05 1940-12-10 Baker Chem Co J T Pharmaceutical preparation
GB613080A (en) * 1946-05-17 1948-11-22 Myer Coplans Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
US2698332A (en) * 1951-04-20 1954-12-28 Reheis Company Inc Aspirin derivative and method of making
GB754364A (en) * 1953-10-09 1956-08-08 Drug Houses Of Australia Ltd Improvements in medicinal preparations containing acetylsalicylic acid
US2918485A (en) * 1955-09-21 1959-12-22 Keystone Chemurgic Corp Dihydroxy aluminum salicylates
US2889248A (en) * 1955-12-13 1959-06-02 Drug Processors Inc Therapeutic composition containing aluminum proteinate
US2801951A (en) * 1956-01-09 1957-08-06 Sterling Drug Inc Stabilized analgesic compositions
GB827529A (en) * 1956-02-27 1960-02-03 Macleans Ltd Improvements in or relating to the manufacture of tablets
US2888382A (en) * 1957-10-28 1959-05-26 Upjohn Co Therapeutic composition and process
NL245245A (no) * 1958-04-18
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US3323992A (en) * 1960-09-29 1967-06-06 Keystone Chemurgic Corp Antacid composition of hydrated magnesium aluminate containing bound sulfate
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
GB1204580A (en) 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3608064A (en) * 1969-10-07 1971-09-21 Anthony H Lamb Milk-buffered aspirin
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule

Also Published As

Publication number Publication date
FI77371B (fi) 1988-11-30
IT8149078A0 (it) 1981-08-10
GB2082456B (en) 1984-10-24
AU549488B2 (en) 1986-01-30
DK159374C (da) 1991-07-01
PT73530B (en) 1983-10-20
IL63577A0 (en) 1981-11-30
SE451667B (sv) 1987-10-26
PT73530A (en) 1981-09-01
NZ198045A (en) 1985-01-31
ZW19781A1 (en) 1982-06-16
FI77371C (fi) 1989-03-10
HU187354B (en) 1985-12-28
NO812678L (no) 1982-02-19
ES8301622A1 (es) 1982-12-16
ES504797A0 (es) 1982-12-16
NO155476B (no) 1986-12-29
DD201643A5 (de) 1983-08-03
DK159374B (da) 1990-10-08
AU7368281A (en) 1982-02-25
SE8104881L (sv) 1982-02-19
IT1143221B (it) 1986-10-22
DE3132518A1 (de) 1982-05-27
NL8103804A (nl) 1982-03-16
CH646331A5 (de) 1984-11-30
DK362781A (da) 1982-02-19
FR2488508A1 (fr) 1982-02-19
ATA355281A (de) 1982-09-15
GB2082456A (en) 1982-03-10
IE811881L (en) 1982-02-18
IE51501B1 (en) 1987-01-07
GR74618B (no) 1984-06-29
US4339428A (en) 1982-07-13
CA1156554A (en) 1983-11-08
FI812505L (fi) 1982-02-19
FR2488508B1 (no) 1985-05-10
AT370624B (de) 1983-04-25
OA06883A (fr) 1983-04-30
LU83559A1 (fr) 1982-04-14

Similar Documents

Publication Publication Date Title
NO155476C (no) Fremgangsmaate til fremstilling av en kapsel inneholdende acetylsalicylsyre.
NO157048C (no) Fremgangsmaate til fremstilling av en tablett.
NL930032I2 (nl) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydronafyridine-3-carbozuren, werkwijzen ter bereiding ervan en deze bevattende geneesmiddelen.
NO812827L (no) Fremgangsmaate for fremstilling av et bacampicillinpreparat
SE450268B (sv) Forfarande for framstellning av en cementhaltig skivbana
NO159061C (no) Fremgangsmaate for fremstilling av en bromhexin-retardform.
DK561177A (da) Kapsel til drikfremstilling
IT8119877A0 (it) Capsula manometrica.
NO153854C (no) Fremgangsmaate for fremstilling av en vandig ionisk polyuretandispersjon.
NO810443L (no) Fremgangsmaate for fremstilling av insulinestere.
DK156878C (da) Fordamper til anaestesimiddel
NO155562C (no) Fremgangsmaate til fremstilling av et vanningsroer.
NO810133L (no) Fremgangsmaate for fremstilling av et avfoeringsmiddel.
NO162669C (no) Fremgangsmaate for fremstilling av en hgprt-manglende human-t-leukemi cellelinje.
NL189948C (nl) Vast farmaceutisch preparaat dat een of een aantal beta-lactamantibiotica bevat.
IT7920764A0 (it) Procedimento per preparare pastiglie contenenti acido 1,4-diidro-1-etil-6-fluoro-4-osso-7-(1-piperazino)chinolin-3-carbossilico.
NO155377C (no) Fremgangsmaate til fremstilling av et stabilisert isotonisk vaeskeformig preparat.
DK93481A (da) Fremgangsmaade til fremstilling af 7-oxo-1-azabicyclo (3.2.0) hept-2-en-carboxylsyre
NO800570L (no) Fremgangsmaate til fremstilling av store islegemer
NO812841L (no) Fremgangsmaate til fremstilling av florerte pentendiaminderivater
DK153994C (da) Dental kapselbeholder til engangsbrug
NO800185L (no) Fremgangsmaate for fremstilling av et disubstituert (n-cyanimido)karbonat.
NO811081L (no) Fremgangsmaate til fremstilling av en stabil, konsentrert opploesning av cisplatina
BE879382A (fr) Capsule a membrane
NO157279C (no) Fremgangsmaate til aa fremstille et akkumulatorbatteri.